[go: up one dir, main page]

PE20170136A1 - Combinacion de un aine y un aminoacido - Google Patents

Combinacion de un aine y un aminoacido

Info

Publication number
PE20170136A1
PE20170136A1 PE2016000218A PE2016000218A PE20170136A1 PE 20170136 A1 PE20170136 A1 PE 20170136A1 PE 2016000218 A PE2016000218 A PE 2016000218A PE 2016000218 A PE2016000218 A PE 2016000218A PE 20170136 A1 PE20170136 A1 PE 20170136A1
Authority
PE
Peru
Prior art keywords
combination
ibuprofen
composition
pharmaceutically acceptable
nsaid
Prior art date
Application number
PE2016000218A
Other languages
English (en)
Inventor
Pelaez Juan Pablo Senosiain
Paniagua Angelica Arzola
Salgado Lopez Enrique Raul Garcia
Original Assignee
Laboratorios Senosiain S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44903664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20170136(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Senosiain S A De C V filed Critical Laboratorios Senosiain S A De C V
Publication of PE20170136A1 publication Critical patent/PE20170136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a una composicion farmaceutica oral que comprende la combinacion de una sal de ibuprofeno o S(+)-ibuprofeno con L-arginina y/o sus sales farmaceuticamente aceptables, adicionalmente, vehiculos y/o excipientes farmaceuticamente aceptables; el proceso de fabricacion de la composicion y el uso de dicha composicion con actividad terapeutica sinergica, indicada para el tratamiento de dolor inflamatorio de moderado a severo, fiebre e inflamacion. Con esta combinacion es posible preservar el efecto terapeutico disminuyendo la cantidad de ibuprofeno y sus posibles efectos adversos tales como nauseas, diarrea, dolor abdominal, mareos, hiperacidez gastrica, entre otros
PE2016000218A 2010-05-04 2016-02-02 Combinacion de un aine y un aminoacido PE20170136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010004974A MX2010004974A (es) 2010-05-04 2010-05-04 Combinacion de un aine y un aminoacido.

Publications (1)

Publication Number Publication Date
PE20170136A1 true PE20170136A1 (es) 2017-03-05

Family

ID=44903664

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2012002113A PE20130316A1 (es) 2010-05-04 2011-04-28 Combinacion de ibuprofeno y l-arginina
PE2016000218A PE20170136A1 (es) 2010-05-04 2016-02-02 Combinacion de un aine y un aminoacido

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2012002113A PE20130316A1 (es) 2010-05-04 2011-04-28 Combinacion de ibuprofeno y l-arginina

Country Status (14)

Country Link
US (1) US9186342B2 (es)
AR (1) AR081007A1 (es)
BR (1) BR112012028300A2 (es)
CA (1) CA2798420C (es)
CL (1) CL2012003065A1 (es)
CO (1) CO6592037A2 (es)
CR (1) CR20120554A (es)
DO (1) DOP2012000280A (es)
EC (1) ECSP13012765A (es)
ES (1) ES2424417B1 (es)
GT (1) GT201200295A (es)
MX (1) MX2010004974A (es)
PE (2) PE20130316A1 (es)
WO (1) WO2011138653A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3996699T3 (pl) 2019-07-09 2023-10-30 Farmalider, S.A. Kombinacja ibuprofenu i tramadolu do uśmierzania bólu
MX393732B (es) * 2019-09-06 2025-03-19 Alparis Sa De Cv Compuestos de curcumina y aminoácidos básicos.
US11969400B2 (en) * 2021-03-23 2024-04-30 Kumara V. Nibhanipudi Ibuprofen for symptomatic treatment of diarrheas in HIV patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US6727286B2 (en) * 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
AU2002224475B2 (en) 2001-11-02 2008-01-17 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
CN101889997B (zh) 2010-07-26 2012-10-03 石家庄中硕药业集团有限公司 一种注射用的含有布洛芬的药物组合物

Also Published As

Publication number Publication date
RU2012151921A (ru) 2014-06-10
US9186342B2 (en) 2015-11-17
DOP2012000280A (es) 2012-12-31
PE20130316A1 (es) 2013-03-17
ECSP13012765A (es) 2013-09-30
CR20120554A (es) 2013-02-01
MX2010004974A (es) 2011-11-23
CA2798420A1 (en) 2011-11-10
AR081007A1 (es) 2012-05-30
US20130109754A1 (en) 2013-05-02
CL2012003065A1 (es) 2013-01-11
GT201200295A (es) 2014-01-03
CO6592037A2 (es) 2013-01-02
ES2424417B1 (es) 2014-11-26
WO2011138653A1 (es) 2011-11-10
BR112012028300A2 (pt) 2016-11-01
CA2798420C (en) 2018-06-05
ES2424417A2 (es) 2013-10-01
ES2424417R1 (es) 2013-12-20

Similar Documents

Publication Publication Date Title
PE20190914A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
CR20120605A (es) Formulación tópica para un inhibidor de jak
AR082167A1 (es) Formas de dosificacion gastrorretentivas
UY32455A (es) Derivados de aminotetralina, composiciones farmacéuticas que la contienen, y sus usos en terapia
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
CO6592098A2 (es) Formulacion estable de mia/cd-rap
MX2021010046A (es) Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas.
BR112014023423A2 (pt) terapia de combinação
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
PE20170136A1 (es) Combinacion de un aine y un aminoacido
BR112012020377A2 (pt) utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
BR112014004732A2 (pt) composto benzotiazolona
UY31826A (es) Compuesto peptídico y su uso
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
ECSP099734A (es) Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
AR093717A1 (es) Composiciones y metodos para el tratamiento de la caries dental
CL2013000085A1 (es) Sal cristalina de (s)-3-[(s)-1-(4-clorofenoxi)-2-metilpropil]pirrolidina y acido clorhidrico en una relacion molar 1:1; composicion farmaceutica; proceso de preparacion; y su uso para el tratamiento del dolor, un trastorno depresivo, un trastorno afectivo, obesidad, entre otras.
CL2012002358A1 (es) Uso de una composicion farmaceutica oral que comprende: i) acido n-[8-(2-hidroxibenzoil)amino] caprilico o una sal del mismo, ii) vitamina b12 y opcionalmente iii) ácido fólico para preparar un medicamento util en el tratamiento de condicionews de deficiencia de vitamina b12.
AR085431A1 (es) Complejo de resinato de doxilamina
ECSP16005679A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
AR077451A1 (es) Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40
IN2014CN04119A (es)

Legal Events

Date Code Title Description
FD Application declared void or lapsed